2 ms·

The Post conveniently left out that the Pharm company found that "Avastin patients had a 30% higher risk of serious systemic side effects than Lucentis patients

• alphaoverlord 13y ago
  The article does mention and debuffs it. Its the difference between 32 and 40% Its based off one study of small sample size and is not biologically plausible. >The incidence of what are known as serious adverse events — a catchall category that includes hospitalizations for any reason — was slightly higher in the Avastin group: 40 percent vs. 32 percent. The adverse events included broken bones and urinary tract infections. “The majority of the adverse events would be difficult to imagine being caused by the drug,” Martin said. Martin noted that while small, probably random effects favored Lucentis in some cases and in others they favored Avastin. Neither should be viewed as conclusively related to the drug, he said. >